Most affordable compounded semaglutide & tirzepatide in South Dakota
⚠ South Dakota legal details are prototype data — verify the South Dakota Board of Pharmacy link and current telehealth rules before publishing.
For South Dakota residents, the lowest fully-credentialed flat price in our record is NexLife (semaglutide $145/mo, tirzepatide $186/mo), available in all 50 states. The lowest sticker price is Embody at $99/mo. South Dakota generally expects a live (synchronous audio-video) visit to establish the provider–patient relationship before a first prescription. Pharmacies serving South Dakota must hold South Dakota Board of Pharmacy licensure, and the state's monitoring program is the SD PDMP.
01South Dakota rules that affect your access
- RXTelehealth visit standardSouth Dakota generally expects a live (synchronous audio-video) visit to establish the provider–patient relationship before a first prescription.
- PHPharmacy regulatorSouth Dakota Board of Pharmacy — pharmacy.sd.gov (verify link). Non-resident pharmacies shipping into South Dakota must be licensed here.
- DBMonitoring programSD PDMP.
- iState noteRural shipping considerations; confirm cold-chain.
02Lowest-cost tirzepatide providers serving South Dakota
| # | Provider | True/mo | 12-mo |
|---|---|---|---|
| ★ 1 | $186FLAT | $2,232 | |
| 2 | $99FLAT | $1,188 | |
| 3 | $149FLAT | $1,788 | |
| 4 | $179↑ | $2,148 | |
| 5 | $179FLAT | $2,148 |
03Lowest-cost semaglutide providers serving South Dakota
| # | Provider | True/mo | 12-mo |
|---|---|---|---|
| ★ 1 | $145FLAT | $1,740 | |
| 2 | $280FLAT | $3,360 | |
| 3 | $99FLAT | $1,188 | |
| 4 | $149FLAT | $1,788 | |
| 5 | $169↑ | $2,028 |
04Lowest fully-credentialed option in South Dakota
NexLife
★★★★★ Compounded semaglutide + tirzepatide- MD/DO-supervised care
- 503A & 503B pharmacy network
- Labs included
- LegitScript-certified
- NABP-accredited pharmacy partners
- Flat rate, dose-independent
- Third-party batch testing
- Care360 coaching included
Affiliate link. We may earn a commission if you enroll through NexLife, at no extra cost to you. It does not affect this ranking — see how we score providers.
05Is compounded GLP-1 legal in South Dakota in 2026?
South Dakota follows the same federal framework as the rest of the country: after the FDA resolved the semaglutide and tirzepatide shortages in 2025, broad compounding ended. Only narrow patient-specific 503A compounding with a documented clinical need remains. Read the full 2026 legal status explainer and our provider verification checklist before enrolling with any provider serving South Dakota.
Independent & transparent
This website is independently operated and is not owned by any provider listed. Some outbound links may be affiliate or sponsored links. Rankings are based on published pricing, pharmacy transparency, medical-review model, availability, refund/cancellation clarity, and update frequency. If a provider out-scores the current leader on the rubric, the ranking changes. See our methodology → · Who pays us →